Related references
Note: Only part of the references are listed.Risk of plasma cell and lymphoproliferative disorders among 14 621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden
Ola Landgren et al.
BLOOD (2009)
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance
Celine M. Vachon et al.
BLOOD (2009)
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Angela Dispenzieri et al.
BLOOD (2008)
Clinically relevant end points and new drug approvals for myeloma
K. C. Anderson et al.
LEUKEMIA (2008)
Prevalence of monoclonal Gammopathy of undetermined significance among men in Ghana
Ola Landgren et al.
MAYO CLINIC PROCEEDINGS (2007)
Prevalence of monoclonal gammopathy of undetermined significance: Study of 52,802 persons in Nagasaki city, Japan
Masako Iwanaga et al.
MAYO CLINIC PROCEEDINGS (2007)
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells
Ernesto Perez-Persona et al.
BLOOD (2007)
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Monoclonal gammopathy of undetermined significance:: Predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size
Laura Rosinol et al.
MAYO CLINIC PROCEEDINGS (2007)
Prevalence of monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma
GS Nowakowski et al.
BLOOD (2005)
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
SV Rajkumar et al.
BLOOD (2005)
Long-term follow-up of 241 patients with monoclonal Gammopathy of undetermined significance: The original Mayo clinic series 25 years later
RA Kyle et al.
MAYO CLINIC PROCEEDINGS (2004)
Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
C Cesana et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A long-term study of prognosis in monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
